NLM Digital Collections

Search

Search Constraints

Start Over You searched for: Subjects United States Remove constraint Subjects: United States Dates by Range 2000 and later Remove constraint Dates by Range: 2000 and later

Search Results

1501. Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff

1502. Same surgical procedure exception under 21 CFR 1271.15(b): questions and answers regarding the scope of the exception

1503. Unique device identification: direct marking of devices : guidance for Industry and Food and Drug administration staff

1504. General principles for evaluating the abuse deterrence of generic solid oral opioid drug products

1505. Pediatric information for x-ray imaging device premarket notifications: guidance for industry and Food and Drug Administration staff

1506. Nucleic acid testing (NAT) for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV): testing, product disposition, and donor deferral and reentry

1507. FDA categorization of investigational device exemption (IDE) devices to assist the Centers for Medicare and Medicaid Services (CMS) with coverage decisions: guidance for sponsors, clinical investigators, industry, institutional review boards, and Food and Drug Administration staff

1508. Technical considerations for additive manufactured medical devices: guidance for industry and Food and Drug Administration staff

1509. Use of serological tests to reduce the risk of transmission of Trypanosoma cruzi infection in blood and blood components

1510. Software as a medical device (SAMD): clinical evaluation : guidance for industry and Food and Drug Administration staff